Gate Diagnostics to Attend AAEP 2025 in Denver

[Denver, Colorado] — Gate Diagnostics is excited to announce its upcoming attendance at the 2025 American Association of Equine Practitioners (AAEP) Annual Convention, taking place December 7–11, where the company will officially introduce Sequre™, its rapid molecular testing platform for equine respiratory disease. The launch of Sequre marks a significant milestone for Gate Diagnostics as the company continues to expand its mission of delivering accessible, high-performance testing for veterinary medicine.

Respiratory disease remains one of the most common and impactful health challenges in horses, yet current diagnostic workflows often rely on centralized laboratory testing that can delay results and complicate clinical decision-making. Sequre is being developed to bring sensitive molecular testing to the stall side, enabling faster answers, improved treatment decisions, and stronger biosecurity practices for equine operations.

AAEP provides an important opportunity for Gate Diagnostics to connect with equine veterinarians, researchers, and industry partners, gather feedback, and share its vision for the future of stall-side molecular testing. The company looks forward to engaging with the equine community and beginning conversations around how Sequre can help advance equine respiratory disease management.

Visit the Gate Diagnostics team at Booth #1109 to learn more about the future of equine care.